Articles by Roger Dabbah - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Articles by Roger Dabbah

Roger Dabbah

director

Roger Dabbah, PhD, is director of Complex Actives, Information, and Standards Development for USP, 12601 Twinbrook Parkway, Rockville, MD 20852. He is director of the board of the Parenteral Drug Association Foundation for Pharmaceutical Sciences. Dr. Dabbah is a member of Pharmaceutical Technology's Editorial Advisory Board.

Articles
More Than You Need to Know about Manufacturing Pharmaceutical Proteins
August 2, 2009

The author of a book about biopharmaceutical production includes irrelevant information.

No Excuse for Nonconformance
March 2, 2009

An updated book provides essential information for scientists who monitor microbial quality.

A Guide That Perplexes
August 2, 2008

Despite its flaws, a recent release fills a need for books about pharmaceutical project management.

The Role of USP in the Assessment of Microbiological Quality of Pharmaceuticals
July 1, 2001

USP ensures the microbiological quality of products by way of the development, proposal, and acceptance of general information chapters.

ADVERTISEMENT

LCGC E-mail Newsletters
Subscribe:Check the box next to each newsletter you wish to subscribe for:
| Weekly
| Monthly
| Monthly | Weekly
 Name:
 E-mail:

Survey
At this month's AAPS Annual Meeting & Exposition, several graduate students were awarded as young innovators. What are your thoughts on innovation and the next generation?
We need more young innovators and more students enrolling in pharma science programs
Our industry has just the right mix of young and old to keep innovation going
Age is irrelevant when it comes to innovation
We need more young innovators and more students enrolling in pharma science programs
25%
Our industry has just the right mix of young and old to keep innovation going
16%
Age is irrelevant when it comes to innovation
59%
View Results
Jim MillerOutsourcing OutlookJim Miller Facing Reality
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advancing Chiral Chemistry in API Synthesis
Faiz kermaniSpotlightFaiz Kermani Demographic time bomb
FindPharma Custom Search
Click here